Enhanced tumor suppression in patient-derived temozolomide-resistant glioblastoma cells using a combination treatment of Olaparib and FK866. Sha X, Li J, Fang Y, Feng J, et al. BMC Cancer 2025;25:1174.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sha X, Li J, Fang Y, Feng J, et al. Enhanced tumor suppression in patient-derived temozolomide-resistant glioblastoma cells using a combination treatment of Olaparib and FK866. BMC Cancer 2025;25:1174.
PMID: 40665223